Cardinal health releases new report on the cell and gene therapy industry

Analysis charts the emergence and future of advanced therapies dublin, ohio , may 7, 2025 /prnewswire/ -- today, cardinal health (nyse: cah) released its 2025 advanced therapies report: revolutionizing patient care – the promise and potential of cell and gene therapies, providing insights into the evolving landscape of cell and gene therapies (cgts). this inaugural report is based on a comprehensive survey of more than 100 healthcare providers as well as interviews with subject matter experts and a patient who received car t-cell therapy, all of whom provide valuable insights into the state of the cgt industry.
CAH Ratings Summary
CAH Quant Ranking